Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ethyl Icosapentate
DRUG
2 trials
Sponsors
M.D. Anderson Cancer Center
, Mochida Pharmaceutical Company, Ltd.
Conditions
Advanced Malignant Neoplasm
Fatigue
Hypertriglyceridemia
Phase 2
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
Terminated
NCT02940223
M.D. Anderson Cancer Center
Advanced Malignant Neoplasm, Fatigue
Start: 2017-03-16
End: 2020-11-24
Updated: 2021-06-10
Phase 3
Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia
Completed
NCT04239950
Mochida Pharmaceutical Company, Ltd.
Hypertriglyceridemia
Start: 2020-05-09
End: 2023-07-20
Updated: 2024-07-15
Related Papers
Efficacy and safety of highly purified ethyl icosapentate soft capsules (MND-21) for the treatment of severe hypertriglyceridemia: A 12-week, multi-center, placebo-controlled, randomized, double-blind, phase III clinical trial in China.
2025-12-14